glp-1 for nash Pharmacological Therapeutics: Current Trends Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Endocrine - Glucagon-like Peptide-1 Receptor-based
Pay in 4 interest-free payments of $5.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 23 - Nov 28



























